Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05500_nanopub.RAB9EDonz_aOySm9KUZCJxd5QxRP7rdy0evK4rVQYzD1c#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05500 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05500 label "AVN-944 [drugbank:DB05500]" assertion.
- drugbank:DB05500 seeAlso DB05500 assertion.
- drugbank:DB05500 description "AVN944 is a biotech drug that demonstrated a statistically meaningful impact on IMPDH and other proteins that are critical to activities in cancer cells, including nucleotide biosynthesis, energy and metabolism, DNA replication, apoptosis and cell cycle control. AVN944 has been associated with cancer cell death in clinical trials. It is being investigated for the treatment of patients with advanced hematologic malignancies." assertion.
- drugbank:DB05500 identifier "drugbank:DB05500" assertion.
- drugbank:DB05500 title "AVN-944" assertion.
- drugbank:DB05500 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05500 drugbank_vocabulary:drugbank-id "DB05500" assertion.
- drugbank:DB05500 bio2rdf_vocabulary:x-identifiers.org DB05500 assertion.
- drugbank:DB05500 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05500" assertion.
- drugbank:DB05500 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05500 bio2rdf_vocabulary:identifier "DB05500" assertion.